Authors | Study design | Participants | Sample size | Average age | Measures | Study outcome |
---|---|---|---|---|---|---|
Al Ateeq et al30 | Cross-sectional | HCWs | n=502 | 18-50 years | PHQ-9, GAD-7 |
|
Al Zaid et al31 | Cross-sectional | HCWs | n=456 | 25-65 years | GAD-7 |
|
Al Hurishi et al32 | Cross-sectional | HCWs | n=200 | 21-41+ years | PHQ-9, GAD-7, ISI-7, IES-22 |
|
Meo et al33 | Cross-sectional | HCWs | n=1678 | 21-61+ years | GAD-7, PSQI |
|
Mohsin et al2 | Cross-sectional | HCWs | n=737 | 18-50 years | COVID-19 fear and anxiety questionnaire, an open-ended question | 10.7% of participants exhibited mild, 73.5% moderate, and 15.7% severe levels of fear and anxiety. |
Al Shehri et al34 | Cross-sectional | HCWs | n=404 | 30-40+ years | PCL-5 |
|
Al Malki et al1 | Cross-sectional | HCWs | n=501 | 18-35+ years | DASS-21 |
|
HCWs: healthcare workers, PHQ: patient health questionnaire, GAD: generalized anxiety disorder, ISI: insomnia severity index, IES: impact of event scale-revised, PSQI: Pittsburgh sleep quality index, COVID-19: coronavirus disease-19, PCL: post-traumatic stress disorder checklist for diagnostic and statistical manual of mental disorders-5, DASS-21: depression, anxiety, and stress scale-21, PTSD: post-traumatic stress disorder